News Releases

News Releases

Aug 31 2020
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
Aug 26 2020
Avid Bioservices Selected by Mapp Biopharmaceutical, Inc. for Clinical Development of Novel Human Monoclonal Antiviral Antibody
Aug 25 2020
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2021 After Market Close on September 1, 2020
Aug 20 2020
Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus Vaccine
Aug 6 2020
Avid Bioservices Selected By Iovance Biotherapeutics to Lead Process Development Through CGMP Manufacturing of Novel IL-2 Analog, IOV-3001
Jul 28 2020
Avid Bioservices and Argonaut Manufacturing Services Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Process Development, Drug Substance Manufacturing and Drug Product Parenteral Manufacturing
Jun 30 2020
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2020 and Recent Developments
Jun 23 2020
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2020 After Market Close on June 30, 2020
Jun 23 2020
Avid Bioservices Names Nicholas Green as President and Chief Executive Officer
Jun 3 2020
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock